Abstract
It is well established that the osteoclast is formed by fusion of post-mitotic, mononuclear precursors1 derived from circulating progenitor cells2. However, the precise haematopoietic origin of the osteoclast is unknown. We have investigated this here by fractionating mouse bone marrow and isolating haematopoietic stem cells using a three-step method combining equilibrium density centrifugation and two fluorescence-activated cell sortings (FACS)3, and have tested the ability of each bone marrow fraction, including highly purified haematopoietic stem cells, to generate osteoclasts during co-culture with preosteoclast-free embryonic long bones4,5. The osteoclast-forming capacity was found to increase with increasing stem cell purity. On the other hand, the culture time needed for osteoclast formation also increased with purification, suggesting the presence of progressively more immature progenitor cells. The pluripotent haematopoietic stem cell fractions with the highest purity needed preincubation with a stem cell-activating factor (interleukin-3) to activate the predominantly quiescent stem cells in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scheven, B. A. A., Burger, E. H., Kawilarang-de Haas, E. W. M., Wassenaar, A. M. & Nijweide, P. J. Lab. Invest. 53, 72–79 (1985).
Marks, S. C. Jr J. oral Path. 12, 226–256 (1983).
Visser, J. W. M., Bauman, J. G. J., Mulder, A. H., Eliason, J. F. & de Leeuw, A. M. J. exp. Med. 159, 1576–1590 (1984).
Burger, E. H. et al. J. exp. Med. 156, 1604–1614 (1982).
Thesingh, C. W. & Burger, E. H. Devl Biol. 95, 429–438 (1983).
Bol, S., Visser, J. & Van den Engh, G. Expl Hemat. 7, 541–553 (1979).
Bol, S. & Williams, N. J. cell. Physiol. 102, 233–243 (1980).
Visser, J. W. M. & Bol, S. J. L. Stem Cells 1, 240–249 (1981).
Baines, P., Bol, S. J. L. & Rosendaal, M. Leukemia Res. 6, 81–88 (1982).
Till, J. E. & McCulloch, E. A. Radiat. Res. 14, 213–222 (1962).
Lahiri, S. K., Keizer, H. J. & van Putten, L. M. Cell Tissue Kinet. 3, 355–362 (1970).
Monette, F. C. & DeMello, J. B. Cell Tissue Kinet. 12, 161–175 (1979).
Dorssers, L., Burger, H. & Wagemaker, G. Expl Hemat. 12, Suppl. 13, abstr. 3 (1984).
Kahn, A. J. & Simmons, D. J. Nature 258, 325–327 (1975).
Walker, D. G. J. exp. Med. 142, 651–663 (1975).
Ash, P., Loutit, J. F. & Townsend, K. M. S. Nature 283, 669–670 (1980).
Loutit, J. F. & Nisbet, N. W. Immunobiology 161, 193–203 (1982).
Visser, J. W. M., Bol, S. J. L. & Van den Engh, G. J. Expl Hemat. 9, 644–655 (1981).
Scheven, B. A. A., Kawilarang-de Haas, E. W. M., Wassenaar, A. M. & Nijweide, P. J. Anat. Rec. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scheven, B., Visser, J. & Nijweide, P. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321, 79–81 (1986). https://doi.org/10.1038/321079a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/321079a0
This article is cited by
-
Biologic Antiresorptive: Denosumab
Indian Journal of Orthopaedics (2023)
-
In vitro and in vivo detection of tunneling nanotubes in normal and pathological osteoclastogenesis involving osteoclast fusion
Laboratory Investigation (2021)
-
Diversity of actin architecture in human osteoclasts: network of curved and branched actin supporting cell shape and intercellular micrometer-level tubes
Molecular and Cellular Biochemistry (2017)
-
Macrophage cathepsin K promotes prostate tumor progression in bone
Oncogene (2013)
-
Novel perspectives on the transcytotic route in osteoclasts
BoneKEy Reports (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.